Association and performance of polygenic risk scores for breast cancer among French women presenting or not a familial predisposition to the disease

被引：6

作者：

Jiao, Yue ^{[1
,2
,3
,4
]}

Truong, Therese ^{[5
]}

Eon-Marchais, Severine ^{[1
,2
,3
,4
]}

Mebirouk, Noura ^{[1
,2
,3
,4
]}

Caputo, Sandrine M. ^{[4
,6
]}

Dondon, Marie-Gabrielle ^{[1
,2
,3
,4
]}

Karimi, Mojgan ^{[5
]}

Le Gal, Dorothee ^{[1
,2
,3
,4
]}

Beauvallet, Juana ^{[1
,2
,3
,4
]}

Le Floch, Edith ^{[7
]}

Dandine-Roulland, Claire ^{[7
]}

Bacq-Daian, Delphine ^{[7
]}

Olaso, Robert ^{[7
]}

Albuisson, Juliette ^{[8
]}

Audebert-Bellanger, Severine ^{[9
]}

Berthet, Pascaline ^{[10
,11
]}

Bonadona, Valerie ^{[12
,45
]}

Buecher, Bruno ^{[4
]}

Caron, Olivier ^{[13
]}

Cavaille, Mathias ^{[14
,15
]}

Chiesa, Jean ^{[16
]}

Colas, Chrystelle ^{[4
,17
]}

Collonge-Rame, Marie-Agnes ^{[18
]}

Coupier, Isabelle ^{[19
,20
]}

Delnatte, Capucine ^{[21
]}

De Pauw, Antoine ^{[4
]}

Dreyfus, Helene ^{[22
,23
]}

Fert-Ferrer, Sandra ^{[24
]}

Gauthier-Villars, Marion ^{[4
]}

Gesta, Paul ^{[25
]}

Giraud, Sophie ^{[26
]}

Gladieff, Laurence ^{[27
]}

Golmard, Lisa ^{[4
]}

Lasset, Christine ^{[12
,45
]}

Lejeune-Dumoulin, Sophie ^{[28
]}

Leone, Melanie ^{[26
]}

Limacher, Jean-Marc ^{[29
]}

Lortholary, Alain ^{[30
,31
]}

Luporsi, Elisabeth ^{[32
]}

Mari, Veronique ^{[33
]}

Maugard, Christine M. ^{[34
,35
]}

Mortemousque, Isabelle ^{[36
]}

Mouret-Fourme, Emmanuelle ^{[4
,6
]}

Nambot, Sophie ^{[8
,37
,46
]}

Nogues, Catherine ^{[38
,39
]}

Popovici, Cornel ^{[38
]}

Prieur, Fabienne ^{[40
]}

Pujol, Pascal ^{[19
,20
]}

Sevenet, Nicolas ^{[41
]}

Sobol, Hagay ^{[38
]}

机构：

[1] INSERM, U900, Paris, France

[2] Inst Curie, Paris, France

[3] Mines ParisTech, Fontainebleau, France

[4] PSL Res Univ, Paris, France

[5] Univ Paris Saclay, Team Exposome & Hered, UVSQ, INSERM,U1018,Gustave Roussy,CESP, Villejuif, France

[6] Inst Curie, Dept Genet, Paris, France

[7] Univ Paris Saclay, Inst Biol Francois Jacob, Ctr Natl Rech Genom Humaine, CEA, Evry, France

[8] Ctr Lutte Canc Georges Francois Leclerc, Dijon, France

[9] CHU Brest, Hop Morvan, Dept Genet Med & Biol Reprod, Brest, France

[10] Ctr Francois Baclesse, Dept Biopathol, Caen, France

[11] INSERM, U1245, Rouen, France

[12] Univ Claude Bernard Lyon 1, Villeurbanne, France

[13] Gustave Roussy, Dept Med Oncol, Villejuif, France

[14] Univ Clermont Auvergne, UMR INSERM, U1240, Clermont Ferrand, France

[15] Ctr Jean Perrin, Dept Oncogenet, Clermont Ferrand, France

[16] CHRU Caremeau, UF Genet Med & Cytogenet, Niimes, France

[17] INSERM, U830, Paris, France

[18] Hop St Jacques, CHU, Serv Genet & Biol Dev Histol, Besancon, France

[19] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Genet Med & Oncogenet, Montpellier, France

[20] CRCM Val Aurelle, INSERM, U896, Montpellier, France

[21] Inst Cancerol Ouest, Unite Oncogenet, St Herblain, France

[22] CHU Grenoble, Clin St Catherine, Grenoble, France

[23] Hop Couple Enfant, Dept Genet, Grenoble, France

[24] Ctr Hosp Chambery, Serv Genet, Chambery, France

[25] CH Georges Renon, Serv Oncogenet Reg Poitou Charentes, Niort, France

[26] Grp Hosp Est, Hosp Civils Lyon, Serv Genet, Bron, France

[27] Inst Claudius Regaud IUCT Oncopole, Serv Oncol Med, Toulouse, France

[28] CHU Lille, Serv Genet Clin Guy Fontaine, Lille, France

[29] Hop Louis Pasteur, Serv Oncohematol, Colmar, France

[30] Ctr Catherine Sienne, Serv Oncol Med, Nantes, France

[31] Hop Prive Confluent, Nantes, France

[32] Hop Mercy, CHR Metz Thionville, Serv Genet UF4128, Metz, France

[33] Ctr Antoine Lacassagne, Unite Oncogenet, Nice, France

[34] Hop Univ Strasbourg, Genet Oncol Mol, UF1422, LBBM,Dept Oncobiol, Strasbourg, France

[35] UF6948 Genet Oncol Clin Evaluat Familiale & Suivi, Strasbourg, France

[36] Hop Bretonneau, Serv Genet, Tours, France

[37] Hop Enfants, CHU Dijon, Inst GIMI, Dijon, France

[38] Inst Paoli Calmettes, Dept Anticipat & Suivi Canc, Oncogenet Clin, Marseille, France

[39] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France

[40] Hop Nord St Etienne, CHU St Etienne, Serv Genet, St Etienne, France

[41] Inst Bergonie, Bordeaux, France

[42] LBM OncoGenAuvergne, Ctr Jean Perrin, Clermont Ferrand, France

[43] Hop Univ Dupuytren, Serv Oncol Med, Limoges, France

[44] Univ Paris Cite, Paris, France

[45] Ctr Leon Berard, Unite Prevent & Epidemiol Genet, CNRS UMR 5558, Lyon, France

[46] Oncogenetique, Dijon, France

来源：

EUROPEAN JOURNAL OF CANCER | 2023年 / 179卷

基金：

加拿大健康研究院;

关键词：

Breast cancer; Genetic susceptibility; BRCA1; BRCA2; SNP; Polygenic risk score; Risk prediction; PREDICTION; RESOURCE;

D O I：

10.1016/j.ejca.2022.11.007

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Three partially overlapping breast cancer polygenic risk scores (PRS) comprising 77, 179 and 313 SNPs have been proposed for European-ancestry women by the Breast Cancer Association Consortium (BCAC) for improving risk prediction in the general population. However, the effect of these SNPs may vary from one country to another and within a country because of other factors. Objective: To assess their associated risk and predictive performance in French women from (1) the CECILE population-based case-control study, (2) BRCA1 or BRCA2 (BRCA1/2) path-ogenic variant (PV) carriers from the GEMO study, and (3) familial breast cancer cases with no BRCA1/2 PV and unrelated controls from the GENESIS study. Results: All three PRS were associated with breast cancer in all studies, with odds ratios per standard deviation varying from 1.7 to 2.0 in CECILE and GENESIS, and hazard ratios vary-ing from 1.1 to 1.4 in GEMO. The predictive performance of PRS313 in CECILE was similar to that reported in BCAC but lower than that in GENESIS (area under the receiver operating characteristic curve (AUC) = 0.67 and 0.75, respectively). PRS were less performant in BRCA2 and BRCA1 PV carriers (AUC = 0.58 and 0.54 respectively).Conclusion: Our results are in line with previous validation studies in the general population and in BRCA1/2 PV carriers. Additionally, we showed that PRS may be of clinical utility for women with a strong family history of breast cancer and no BRCA1/2 PV, and for those car-rying a predicted PV in a moderate-risk gene like ATM, CHEK2 or PALB2.2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

引用

页码：76 / 86

页数：11

共 50 条

[31] Multimodality breast cancer screening in women with a familial or genetic predisposition
Trop, I.
Lalonde, L.
Mayrand, M. H.
David, J.
Larouche, N.
Provencher, D.
CURRENT ONCOLOGY, 2010, 17 (03) : 28 - 36
[32] RISK PERCEPTIONS AND PRACTICES AMONG WOMEN WITH A GENETIC PREDISPOSITION TO BREAST-CANCER
LERMAN, C
DALY, M
SANDS, C
ROSS, E
BUETOW, K
ENGSTROM, P
AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 314 - 314
[33] Polygenic risk scores for prediction of breast cancer risk in women of African ancestry: a cross-ancestry approach
Gao, Guimin
Zhao, Fangyuan
Ahearn, Thomas U.
Lunetta, Kathryn L.
Troester, Melissa A.
Du, Zhaohui
Ogundiran, Temidayo O.
Ojengbede, Oladosu
Blot, William
Nathanson, Katherine L.
Domchek, Susan M.
Nemesure, Barbara
Hennis, Anselm
Ambs, Stefan
McClellan, Julian
Nie, Mark
Bertrand, Kimberly
Zirpoli, Gary
Yao, Song
Olshan, Andrew F.
Bensen, Jeannette T.
Bandera, Elisa, V
Nyante, Sarah
Conti, David, V
Press, Michael F.
Ingles, Sue A.
John, Esther M.
Bernstein, Leslie
Hu, Jennifer J.
Deming-Halverson, Sandra L.
Chanock, Stephen J.
Ziegler, Regina G.
Rodriguez-Gil, Jorge L.
Sucheston-Campbell, Lara E.
Sandler, Dale P.
Taylor, Jack A.
Kitahara, Cari M.
O'Brien, Katie M.
Bolla, Manjeet K.
Dennis, Joe
Dunning, Alison M.
Easton, Douglas F.
Michailidou, Kyriaki
Pharoah, Paul D. P.
Wang, Qin
Figueroa, Jonine
Biritwum, Richard
Adjei, Ernest
Wiafe, Seth
Ambrosone, Christine B.
HUMAN MOLECULAR GENETICS, 2022, : 3133 - 3143
[34] Development of a Breast Cancer Risk Prediction Model Incorporating Polygenic Risk Scores and Nongenetic Risk Factors for Korean Women
Choi, Jihye
Ha, Tae-Woong
Choi, Hye-Mi
Lee, Han-Byoel
Shin, Hee-Chul
Chung, Woosung
Han, Wonshik
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2023, 32 (09) : 1182 - 1189
[35] The joint effects of polygenic risk scores and pathogenic variants in cancer predisposition genes on breast cancer risk in the general population: results from the CARRIERS study
Gao, Chi
Hu, Chunling
Hart, Steven N.
Gnanaolivu, Rohan
Lee, Kun Y.
Lilyquist, Jenna
Boddicker, Nicholas J.
Eckloff, Bruce
Samara, Raed
Klebba, Josh
Auer, Paul
Bernstein, Leslie
Gaudet, Mia
Anton-Culver, Hoda
Trentham-Dietz, Amy
Palmer, Julie R.
Yao, Song
Haiman, Christopher
Olson, Janet E.
Domchek, Susan
Weitzel, Jeffrey
Goldgar, David
Nathanson, Katherine L.
Polley, Eric C.
Couch, Fergus J.
Kraft, Peter
CANCER RESEARCH, 2019, 79 (13)
[36] Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis
Marijke C. Jansen-van der Weide
Marcel J. W. Greuter
Liesbeth Jansen
Jan C. Oosterwijk
Ruud M. Pijnappel
Geertruida H. de Bock
European Radiology, 2010, 20 : 2547 - 2556
[37] Exposure to low-dose radiation and the risk of breast cancer among women with a familial or genetic predisposition: a meta-analysis
Jansen-van der Weide, Marijke C.
Greuter, Marcel J. W.
Jansen, Liesbeth
Oosterwijk, Jan C.
Pijnappel, Ruud M.
de Bock, Geertruida H.
EUROPEAN RADIOLOGY, 2010, 20 (11) : 2547 - 2556
[38] Assessing the Risk Stratification of Breast Cancer Polygenic Risk Scores in a Brazilian Cohort
Barreiro, Rodrigo A. S.
de Almeida, Tatiana F.
Gomes, Catarina
Monfardini, Frederico
de Farias, Allysson A.
Tunes, Gabriela C.
de Souza, Gabriel M.
Duim, Etienne
de Sa Correia, Jaqueline
Coelho, Antonio V. Campos
Caraciolo, Marcel P.
Duarte, Yeda A. Oliveira
Zatz, Mayana
Amaro, Edson
Oliveira, Joao B.
Bitarello, Barbara D.
Brentani, Helena
Naslavsky, Michel S.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (09): : 825 - 831
[39] Familial risk factors for breast cancer among Arab women in Israel
Aghassi-Ippen, M
Green, MS
Shohat, T
EUROPEAN JOURNAL OF CANCER PREVENTION, 2002, 11 (04) : 327 - 331
[40] Prospective Evaluation of the Addition of Polygenic Risk Scores to Breast Cancer Risk Models
Li, Sherly X.
Milne, Roger L.
Nguyen-Dumont, Tu
Wang, Xiaochuan
English, Dallas R.
Giles, Graham G.
Southey, Melissa C.
Antoniou, Antonis C.
Lee, Andrew
Li, Shuai
Winship, Ingrid
Hopper, John L.
Terry, Mary Beth
MacInnis, Robert J.
JNCI CANCER SPECTRUM, 2021, 5 (03)

← 1 2 3 4 5 →